Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
45,885
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,241
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
16 Diseases matching "Bladder Cancer"
Bladder cancer
Bladder Cancer Stage Iv
Bladder Cancer Recurrent
Bladder Cancer, Transitional Cell, Somatic
Bladder Neoplasm
Gallbladder Neoplasm
Gallbladder Carcinoma
Stage, Bladder Cancer
Malignant Neoplasm of Gallbladder
Stage 0 Gallbladder Cancer Ajcc V8
Stage Iv Gallbladder Cancer Ajcc V8
Stage Iia Gallbladder Cancer Ajcc V8
Stage Iib Gallbladder Cancer Ajcc V8
Stage Iii Gallbladder Cancer Ajcc V8
Malignant Neoplasm of Urinary Bladder
Carcinoma of Urinary Bladder, Superficial
🏥 Disease / Health Topic
Bladder cancer
36
Clinical Trials
11
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00118040
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
Completed · Phase 2
NCT01489813
Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment
Active_Not_Recruiting · Phase 2
NCT04046094
Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients
Active_Not_Recruiting · Phase 1|Phase 2
📊 Sample Meta-Analyses
CRD42016053826
A protocol for systematic review and meta-analysis of the estimated odds ratios for the opium effect on bladder cancer
Bladder cancer is responsible for more than 7% of neoplasms especially among men
CRD42018112605
A systematic review of community-based drinking water interventions to mitigate arsenic exposure in lower-income countries
The review focuses on community-based interventions that aim to reduce participa
CRD42019141632
Urinary arsenic level and diabetes: a dose-response meta-analysis
Chronic arsenic exposure is associated with a variety of adverse health outcomes
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Bladder cancer
🏥 Names
Disease Name
Bladder cancer
Topic Type
disease
🔍 Raw view — every non-empty column on this row (14 fields)
name
Bladder cancer
topic type
disease
tcmsp disease id
103
📋 Clinical Trials
12 · subject of clinical studyNCT00118040 Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
→ Recurrent Bladder Carcinoma|Stage I Bladder Cancer
NCT01489813 Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatm
→ Bladder Cancer
NCT04046094 Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Ca
→ Bladder Cancer
NCT00033436 Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients
→ Bladder Cancer
NCT00365508 Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smokin
→ Bladder Cancer|Cervical Cancer|Esophageal Cancer|G
NCT00790569 Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone
→ Bladder Cancer|Cervical Cancer|Esophageal Cancer|G
NCT00002917 Paclitaxel in Treating Patients With Early-Stage Bladder Cancer
→ Bladder Cancer
NCT00002949 Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Adva
→ Bladder Cancer|Cervical Cancer|Endometrial Cancer|
NCT00022191 Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With
→ Bladder Cancer|Transitional Cell Cancer of the Ren
NCT00055835 S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplati
→ Bladder Cancer|Urethral Cancer
NCT00136175 Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanc
→ Bladder Cancer
NCT00238420 Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patient
→ Bladder Urothelial Carcinoma|Stage I Bladder Cance
📊 Meta-Analyses
11 · systematic reviewCRD42016053826 A protocol for systematic review and meta-analysis of the estimated odds ratios
→ Bladder cancer is responsible for more than 7% of
CRD42018112605 A systematic review of community-based drinking water interventions to mitigate
→ The review focuses on community-based intervention
CRD42019141632 Urinary arsenic level and diabetes: a dose-response meta-analysis
→ Chronic arsenic exposure is associated with a vari
CRD42022381522 Arsenic in drinking water and urinary tract cancers: a systematic review update
→ Urinary bladder cancer and kidney cancer
CRD42019123716 Comparison between fluoropyrimidine-cisplatin and gemcitabine-cisplatin as first
→ Advanced biliary tract cancer (cholangiocarcinoma
CRD42020196422 Comparision of oncologic outcomes associated with neoadjuvant chemotherapy Dose
→ Muscle invasive bladder cancer
CRD42021289342 Therapeutic effects and mechanisms of action of epigallocatechin gallate on blad
→ Bladder cancer is a common urinary cancer worldwid
CRD42021289342 Therapeutic effects and mechanisms of action of epigallocatechin gallate on blad
→ Bladder cancer is a common urinary cancer worldwid
CRD42014013093 Vitamin D and prostate cancer: a systematic review of the literature
→ Cancer (prostate and bladder cancer), Nutrition (h
CRD42019140284 Correlations between ApaI, BsmI, FokI, and TaqI polymorphisms in the vitamin D r
→ Bladder cancer (BCa) is the ninth most common freq
CRD42023448504 Meta-analysis of the clinical efficacy and safety of Compound Kushen Injection c
→ To systematically evaluate the efficacy and safety
How to read these connections
Each box lists records connected to the one you are viewing, and says how the connection was made. A connection shows that two records are related in the source data. It does not show that something works, is safe or should be used, and a record with many connections is not necessarily better studied or more effective.
- Study records (trials, systematic reviews, publications): the study names this subject. Registered or ongoing studies have no results here, and animal or cell research does not show an effect in people.
- Source-database links (for example herb and compound, compound and gene target): taken from the imported databases and not independently checked by us.
- Name matches (for example formula and herb, or a condition named in a study): found by matching names, so they can be wrong. Treat them as leads, not findings.